Corrigendum to "Ginsenoside compound K protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury via inhibition of nuclear factor-kB, p38, and JNK MAPK pathways" [J Ginseng Res 43 (2019) 95-104]

Shan Lu^{1

2

3

4}, Yun Luo^{1

2

3

4}, Ping Zhou^{1

2

3

4}, Ke Yang^{1

2

3

4}, Guibo Sun^{1

2

3

4}, Xiaobo Sun^{1

2

3

4}

Affiliations

¹ Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
² Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China.
³ Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China.
⁴ Key Laboratory of efficacy evaluation of Chinese Medicine against glycolipid metabolism disorder disease, State Administration of Traditional Chinese Medicine, China.

Published Erratum

Shan Lu et al. J Ginseng Res. 2024 Nov.

. 2024 Nov;48(6):627.

doi: 10.1016/j.jgr.2024.09.001. Epub 2024 Sep 2.

Shan Lu^{1

2

3

4}, Yun Luo^{1

2

3

4}, Ping Zhou^{1

2

3

4}, Ke Yang^{1

2

3

4}, Guibo Sun^{1

2

3

4}, Xiaobo Sun^{1

2

3

4}

¹ Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
² Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, China.
³ Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine, China.
⁴ Key Laboratory of efficacy evaluation of Chinese Medicine against glycolipid metabolism disorder disease, State Administration of Traditional Chinese Medicine, China.